North America Syringe Infusion Pumps Market 2030: The Shift to Outpatient Care

The North America syringe infusion pumps market was valued at USD 645.1 million in 2024 and is expected to grow to USD 1.04 billion by 2030, with a compound annual growth rate (CAGR) of 8.4% between 2025 and 2030. The market growth in this region is primarily driven by the increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes, and respiratory illnesses. These conditions require precise and continuous medication delivery, which syringe infusion pumps enable by accurately dosing critical drugs like chemotherapy agents and insulin. Since about six in ten adults in North America suffer from at least one chronic condition, the demand for dependable infusion devices in both hospital and outpatient care settings continues to rise, highlighting the vital role of these pumps in patient management.

The growing number of surgical procedures and intensive care unit (ICU) admissions further supports the syringe infusion pump market expansion. These pumps are essential in critical care settings, ensuring the precise delivery of anesthetics, analgesics, and vasoactive medications during surgeries and for critically ill patients. A report by the Washington Post in March 2025 projects that annual hospitalizations in the U.S. will increase from 36 million in 2025 to 40 million by 2035, which will further increase the need for reliable infusion devices to ensure accurate medication administration.

Technological advancements in smart infusion technologies are another key factor driving market growth. The incorporation of features such as Dose Error Reduction Systems (DERS), wireless connectivity, and compatibility with electronic health records (EHR) enhances medication safety and administration efficiency. North America’s leadership in adopting these advanced infusion systems enables healthcare providers to improve protocol adherence, reduce medication errors, and enhance clinical decision-making and patient safety.

The growth of home healthcare and ambulatory care settings has created rising demand for portable, easy-to-use syringe infusion pumps, especially driven by the aging population and healthcare cost management efforts. These devices facilitate safe medication delivery outside traditional hospital environments, improving patient outcomes and quality of life. Combined with favorable regulatory frameworks and reimbursement policies, these factors are expected to sustain market growth and innovation in the region.

Order a free sample PDF of the North America Syringe Infusion Pumps Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights:

• The pediatrics/neonatology segment dominated the market in 2024, accounting for 26.5% of revenue. The increasing number of births, including preterm and low-birth-weight infants, has heightened the reliance on specialized infusion devices. Advances in smart pump technology, featuring Dose Error Reduction Systems and electronic medical record (EMR) integration, have significantly reduced medication errors in this segment.
• Hospitals accounted for 40.5% of the market revenue in 2024. Demand is especially strong in critical care, oncology, and pediatric hospital units, where precise syringe infusion pumps are crucial for the controlled delivery of small-volume medications essential for complex therapies and reducing medication errors.

Market Size & Forecast:

• 2024 Market Size: USD 645.1 Million
• 2030 Projected Market Size: USD 1.04 Billion
• CAGR (2025–2030): 8.4%

Key North America Syringe Infusion Pumps Companies:

The market is highly competitive, with leading companies leveraging technological innovation, FDA approvals, and strategic partnerships to maintain their market positions. Some prominent players include Baxter, B. Braun Medical Inc., Fresenius Kabi AG, ICU Medical, Inc., and Micrel Medical Devices SA.

• ICU Medical offers products like the Medfusion 4000, a wireless syringe infusion pump designed for precise small-volume drug delivery with broad syringe compatibility and seamless connectivity. It is widely used in critical care, pediatric, and anesthesia settings to enhance safety and operational efficiency.
• Micrel Medical Devices SA produces advanced syringe infusion pumps such as the Micropump MP mlh+ Multi Syringe, suitable for both hospital and homecare environments. These portable, easy-to-use devices support therapies including pain management and immunoglobulin infusions, addressing the needs of outpatient and long-term care.

Additional major companies operating in the North American syringe infusion pump market include Boston Scientific Corporation, BD, Terumo Corporation, Moog Inc., IRadimed Corporation, CODAN Companies, and ACROMED.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The North America syringe infusion pumps market is expected to experience robust growth through 2030, driven by the increasing prevalence of chronic diseases, rising surgical procedures, and expanding ICU admissions. Technological advancements, particularly in smart infusion systems, enhance medication safety and operational efficiency, making these devices indispensable in critical care and pediatric settings. Furthermore, the growing home healthcare sector, supported by favorable regulatory and reimbursement policies, is contributing to increased demand for portable and user-friendly syringe pumps. With competitive innovation and expanding applications across healthcare settings, the market is well-positioned for sustained growth and continued technological progress in the region.